Ward A. Heggermont
Ward A. Heggermont
MD PhD MMed MSc
Geverifieerd e-mailadres voor olvz-aalst.be - Homepage
Titel
Geciteerd door
Geciteerd door
Jaar
Fatty acid carbon is essential for dNTP synthesis in endothelial cells
S Schoors, U Bruning, R Missiaen, KCS Queiroz, G Borgers, I Elia, ...
Nature 520 (7546), 192-197, 2015
3282015
The RNA-binding protein HuR is essential for the B cell antibody response
MD Diaz-Muñoz, SE Bell, K Fairfax, E Monzon-Casanova, ...
Nature immunology 16 (4), 415-425, 2015
962015
The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C
AM De Palma, W Heggermont, K Lanke, B Coutard, M Bergmann, ...
Journal of Virology 82 (10), 4720-4730, 2008
722008
The microRNA-221/-222 cluster balances the antiviral and inflammatory response in viral myocarditis
MF Corsten, W Heggermont, AP Papageorgiou, S Deckx, A Tijsma, ...
European heart journal 36 (42), 2909-2919, 2015
702015
Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307
AM De Palma, HJ Thibaut, L van der Linden, K Lanke, W Heggermont, ...
Antimicrobial agents and chemotherapy 53 (5), 1850-1857, 2009
702009
Anti-enterovirus activity and structure–activity relationship of a series of 2, 6-dihalophenyl-substituted 1H, 3H-thiazolo [3, 4-a] benzimidazoles
AM De Palma, W Heggermont, P Leyssen, G Pürstinger, E Wimmer, ...
Biochemical and biophysical research communications 353 (3), 628-632, 2007
482007
Metabolic support for the heart: complementary therapy for heart failure?
WA Heggermont, AP Papageorgiou, S Heymans, M van Bilsen
European journal of heart failure 18 (12), 1420-1429, 2016
472016
MicroRNAs are involved in end-organ damage during hypertension
WA Heggermont, S Heymans
Hypertension 60 (5), 1088-1093, 2012
442012
RNA profiling in human and murine transplanted hearts: identification and validation of therapeutic targets for acute cardiac and renal allograft rejection
LNL Van Aelst, G Summer, S Li, SK Gupta, W Heggermont, K De Vusser, ...
American Journal of Transplantation 16 (1), 99-110, 2016
352016
Inhibition of MicroRNA-146a and overexpression of its target dihydrolipoyl succinyltransferase protect against pressure overload-induced cardiac hypertrophy and dysfunction
WA Heggermont, AP Papageorgiou, A Quaegebeur, S Deckx, P Carai, ...
Circulation 136 (8), 747-761, 2017
332017
Endothelium-enriched microRNAs as diagnostic biomarkers for cardiac allograft vasculopathy
N Singh, W Heggermont, S Fieuws, J Vanhaecke, J Van Cleemput, ...
The Journal of Heart and Lung Transplantation 34 (11), 1376-1384, 2015
322015
Osteoglycin prevents the development of age-related diastolic dysfunction during pressure overload by reducing cardiac fibrosis and inflammation
S Deckx, W Heggermont, P Carai, M Rienks, T Dresselaers, ...
Matrix Biology 66, 110-124, 2018
222018
NF-κB-mediated metabolic remodelling in the inflamed heart in acute viral myocarditis
AHV Remels, WJA Derks, B Cillero-Pastor, KJP Verhees, MC Kelders, ...
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (8 …, 2018
212018
Liver X receptor activation enhances CVB3 viral replication during myocarditis by stimulating lipogenesis
AP Papageorgiou, W Heggermont, M Rienks, P Carai, L Langouche, ...
Cardiovascular research 107 (1), 78-88, 2015
162015
Adherence, knowledge, and perception about oral anticoagulants in patients with atrial fibrillation at high risk for thromboembolic events after radiofrequency ablation
L Smet, WA Heggermont, E Goossens, K Eeckloo, R Vander Stichele, ...
Journal of advanced nursing 74 (11), 2577-2587, 2018
112018
Leptin-adiponectin ratio in pre-diabetic patients undergoing percutaneous coronary intervention
PAH Nguyen, WA Heggermont, M Vanhaverbeke, C Dubois, T Vydt3, ...
Acta cardiologica 70 (6), 640-646, 2015
112015
Antioxidant treatment improves cardiac dysfunction in a murine model of premature aging
B Hemmeryckx, P Hohensinner, M Swinnen, W Heggermont, J Wojta, ...
Journal of cardiovascular pharmacology 68 (5), 374-382, 2016
102016
A case of HELLP syndrome: an immuno-“logical” approach
WA Heggermont, C Verhelst, K De Wilde, M De Paepe, F Lacquet, ...
Acta Clinica Belgica 67 (5), 375-377, 2012
82012
Treatment of diuretic resistance with a novel percutaneous blood flow regulator: concept and initial experience
R Dierckx, M Vanderheyden, W Heggermont, M Goethals, S Verstreken, ...
Journal of cardiac failure 25 (11), 932-934, 2019
62019
Technology advances to improve response to cardiac resynchronization therapy: what clinicians should know
A Auricchio, WA Heggermont
Revista Española de Cardiología (English Edition) 71 (6), 477-484, 2018
62018
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20